Gilead suspends business operations in Russia

Gilead, a US biopharmaceutical company, has suspended all business operations in Russia that are not related to life-saving drugs. This is stated in the message on the company’s website.
The company announced the suspension of the creation of new centers for clinical trials in Moscow and Kyiv. In addition, the proceeds from the sale of medicines will be directed to humanitarian aid to Ukraine.